Anouk Schrantee - Publications

Pre-prints

Boucherie DE, Reneman L, Booij J, Immink R, Hollmann MW, Schrantee A. Concurrent assessment of neurometabolism and brain hemodynamics to comprehensively characterize the functional brain response to psychotropic drugs: an S-ketamine study. bioRxiv. 2024; doi:10.1101/2024.07.23.604721
Van der Pal Z, Reneman L, Mutsaerts HJMM, Kaiser A, Bottelier MB, Geurts HM, Schrantee A. Association between long-term stimulant treatment and the functional brain response to methylphenidate in adolescents and adults with attention-deficit/hyperactivity disorder. medRxiv 2024.12.30.24319766; doi: 10.1101/2024.12.30.24319766

2025

van den Bergh, D., Douw, L., van der Pal, Z., Blanken, T., Schrantee, A., & Marsman, M. Jointly Estimating Individual and Group Networks from fMRI Data. Network Neuroscience, in press.
Boots A, Damoiseaux JS, Jung Y, Wiegersma AM, Schrantee A, Boucherie DE, Roseboom TJ, de Rooij SR. Prenatal famine exposure and late-life functional brain network connectivity: A longitudinal study. Brain Res. 2025 Jul 24;1865:149859. doi: 10.1016/j.brainres.2025.149859. Epub ahead of print. PMID: 40714007.
Afzali-Hashemi L, Franse M, Baas KPA, Schrantee A, Nur E, Wood JC, Nederveen AJ, Biemond BJ, O’Neil SH. Assessment of neurocognitive functioning in sickle cell disease and thalassaemia and the association with silent cerebral infarcts, cerebral haemodynamics and oxygen metabolism. Br J Haematol. 2025 Jun 4. doi: 10.1111/bjh.20181. Epub ahead of print. PMID: 40468521.
van der Pal Z, Douw L, Genis A, van den Bergh D, Marsman M, Schrantee A, Blanken TF. Tell me why: A scoping review on the fundamental building blocks of fMRI-based network analysis. Neuroimage Clin. 2025 Apr 13;46:103785. doi: 10.1016/j.nicl.2025.103785.
Chen M, van der Pal Z, Poirot MG, Schrantee A, Bottelier M, Kooij SJJ, Marquering HA, Reneman L, Caan MWA. Prediction of methylphenidate treatment response for ADHD using conventional and radiomics T1 and DTI features: Secondary analysis of a randomized clinical trial. Neuroimage Clin. 2025;45:103707. doi: 10.1016/j.nicl.2024.103707.
Poirot MG*, Boucherie DE*, Caan MWA, Goya-Maldonado R, Belov V, Corruble E, Colle R, Couvy-Duchesne B, Kamishikiryo T, Shinzato H, Ichikawa N, Okada G, Okamoto Y, Harrison BJ, Davey CG, Jamieson AJ, Cullen KR, Başgöze Z, Klimes-Dougan B, Mueller BA, Benedetti F, Poletti S, Melloni EMT, Ching CRK, Zeng LL, Radua J, Han LKM, Jahanshad N, Thomopoulos SI, Pozzi E, Veltman DJ, Schmaal L, Thompson PM, Ruhe HG, Reneman L, ENIGMA Major Depressive Disorder working group, Schrantee A. Predicting Antidepressant Treatment Response from Cortical Structure on MRI: A Mega-Analysis from the ENIGMA-MDD Working Group. Human Brain Mapping, doi: 10.1002/hbm.70053. Erratum in: Hum Brain Mapp. 2025 Feb 1;46(2):e70144. doi: 10.1002/hbm.70144.

2024

Afzali-Hashemi L, Baas KPA, Schrantee A, Nur E, Vu C, Choi S, Suriany S, Wood JC, Nederveen AJ, Biemond BJ. Cerebral hemodynamics and oxygen metabolism in patients with milder and severe forms of sickle cell disease and thalassemia. Hemasphere. 2024 Dec 2;8(12):e70022. doi: 10.1002/hem3.70022.
van der Pal Z, Geurts HM, Haslbeck JMB, van Keeken A, Bruijn AM, Douw L, van Rooij D, Franke B, Buitelaar J, Lambregts-Rommelse N, Hartman C, Oosterlaan J, Luman M, Reneman L, Hoekstra PJ, Blanken TF, Schrantee A. Stimulant medication and symptom interrelations in children, adolescents and adults with attention-deficit/hyperactivity disorder. Eur Child Adolesc Psychiatry. 2024 Nov 11. doi: 10.1007/s00787-024-02610-8.
Konté K, Afzali-Hashemi L, Baas KPA, Schrantee A, Wood JC, Nur E, Nederveen AJ, Biemond BJ. Effect of voxelotor on cerebral perfusion and cerebral oxygen metabolism and cardiac stress in adult patients with sickle cell disease. Am J Hematol. 2025 Jan;100(1):78-84. doi: 10.1002/ajh.27522.
de Joode NT, van den Heuvel OA, Koster M, Clarke WT, van Balkom AJLM, Schrantee A*, Vriend C*. Glutamate dynamics and BOLD response during OCD symptom provocation in the lateral occipital cortex: A 7 Tesla fMRI-fMRS study. J Affect Disord. 2024 Sep 2;367:416-425. doi: 10.1016/j.jad.2024.08.216.
Koster M, van der Pluijm M, van de Giessen E, Schrantee A, van Hooijdonk CFM, Selten JP, Booij J, de Haan L, Ziermans T, Vermeulen J. The association of tobacco smoking and metabolite levels in the anterior cingulate cortex of first-episode psychosis patients: A case-control and 6-month follow-up ¹H-MRS study. Schizophr Res. 2024 Jul 18;271:144-152. doi: 10.1016/j.schres.2024.07.022.
van Hooijdonk CFM, Balvers MGJ, van der Pluijm M, Smith CLC, de Haan L, Schrantee A, Yaqub M, Witkamp RF, van de Giessen E, van Amelsvoort TAMJ, Booij J, Selten JP. Endocannabinoid levels in plasma and neurotransmitters in the brain: a preliminary report on patients with a psychotic disorder and healthy individuals. Psychol Med. 2024 Jul;54(9):2189-2199. doi: 10.1017/S0033291724000291.
van der Pluijm M, Alting M, Schrantee A, Edden RAE, Booij J, de Haan L, van de Giessen E. Glutamate and GABA levels in the anterior cingulate cortex in treatment resistant first episode psychosis patients. Schizophr Res. 2024 Feb;264:471-478. doi: 10.1016/j.schres.2024.01.025.
Boots A, Schrantee A, Wiegersma AM, Aflalo S, Groot PFC, Roseboom TJ, de Rooij SR. Brain activity during Stroop task performance at age 74 after exposure to the Dutch famine during early gestation. Brain Cogn. 2024 Jun;177:106162. doi: 10.1016/j.bandc.2024.106162.
van der Pal Z, Walhovd KB, Amlien IK, Guichelaar CJ, Kaiser A, Bottelier MA, Geurts HM, Reneman L, Schrantee A. Stimulant medication use and apparent cortical thickness development in attention-deficit/hyperactivity disorder: a prospective longitudinal study. Front Psychiatry. 2024 May 7;15:1365159. doi: 10.3389/fpsyt.2024.1365159.
Belov V, Erwin-Grabner T, …, Schrantee A, …, Veltman DJ, Schmaal L, Thompson PM, Goya-Maldonado R; ENIGMA Major Depressive Disorder working group. Multi-site benchmark classification of major depressive disorder using machine learning on cortical and subcortical measures. Sci Rep. 2024 Jan 11;14(1):1084. doi: 10.1038/s41598-023-47934-8.
van de Weijer MP, Vermeulen J, Schrantee A, Munafò MR, Verweij KJH, Treur JL. The potential role of gray matter volume differences in the association between smoking and depression: A narrative review. Neurosci Biobehav Rev. 2023 Dec 13;156:105497. doi: 10.1016/j.neubiorev.2023.105497 .

2023

Wijdeveld M, Schrantee A, Hagemeijer A, Nederveen AJ, Scheithauer TPM, Levels JHM, Prodan A, de Vos WM, Nieuwdorp M, Ijzerman RG. Intestinal acetate and butyrate availability is associated with glucose metabolism in healthy individuals. iScience. 2023 Nov 16;26(12):108478. doi: 10.1016/j.isci.2023.108478
Boucherie DE, Reneman L, Booij J, Martins D, Dipasquale O*, Schrantee A*. Modulation of functional networks related to the serotonin neurotransmitter system by citalopram: Evidence from a multimodal neuroimaging study. J Psychopharmacol. 2023 Dec;37(12):1209-1217. doi: 10.1177/02698811231211154
Boucherie DE, Reneman L, Ruhé HG, Schrantee A. Neurometabolite changes in response to antidepressant medication: A systematic review of 1H-MRS findings. Neuroimage Clin. 2023;40:103517. doi: 10.1016/j.nicl.2023.103517
Schrantee A, Najac C, Jungerius C, van der Zwaag W, Jbabdi S, Clarke WT, Ronen I. (2023) A 7T interleaved fMRS and fMRI study on visual contrast dependency in the human brain. Imaging Neuroscience, accepted. doi: 10.1162/imag_a_00031
Hendriks J, Mutsaerts HJ, Joules R, Peña-Nogales Ó, Rodrigues PR, Wolz R, Burchell GL, Barkhof F, Schrantee A. A systematic review of (semi-)automatic quality control of T1-weighted MRI scans. Neuroradiology. 2023 Dec 4. doi: 10.1007/s00234-023-03256-0
Afzali-Hashemi L, Dovern E, Baas KPA, Schrantee A, Wood JC, Nederveen AJ, Nur E, Biemond BJ. Cerebral hemodynamics and oxygenation in adult patients with sickle cell disease after stem cell transplantation. Am J Hematol. 2023 Oct 19. doi: 10.1002/ajh.27135.
Slomp M, de Lange IGS, Mul JD, Schrantee A*, la Fleur SE*. Investigating Habenula Functional Connectivity and Reward-Related Activity in Obesity Using Human Connectome Project Data. Brain Connect. 2023 Nov;13(9):541-552. doi: 10.1089/brain.2023.0034
van Galen KA, Schrantee A, Ter Horst KW, la Fleur SE, Booij J, Constable RT, Schwartz GJ, DiLeone RJ, Serlie MJ. Brain responses to nutrients are severely impaired and not reversed by weight loss in humans with obesity: a randomized crossover study. Nat Metab. 2023 Jun;5(6):1059-1072. doi: 10.1038/s42255-023-00816-9

2022

Breedt L, Santos FAN, Hillebrand A, Reneman L, Rootselaar AF van, Schoonheim MM, Stam CJ, Ticheler A, Tijms BM, Veltman DJ, Vriend C, Wagenmakers MJ, Wingen GA van, Geurts JJG, Schrantee A, Douw L. Multimodal Multilayer Network Centrality Relates to Executive Functioning. 2022 Network Neuroscience 1–45. doi: /10.1162/netn_a_00284
van Genderen JG, Chia C, Van den Hof M, Mutsaerts HJMM, Reneman L, Pajkrt D, Schrantee A. Brain Differences in Adolescents Living With Perinatally Acquired HIV Compared to Adoption Status Match Controls: A Cross-Sectional Study. Neurology. 2022 ;99(15):e1676–84. doi: 10.1212/WNL.0000000000200946.
Kaiser A, Broeder C, Cohen JR, Douw L, Reneman L, Schrantee A. Effects of a single-dose methylphenidate challenge on resting-state functional connectivity in stimulant-treatment naive children and adults with ADHD. Hum Brain Mapp. 2022; 43(15):4664-4675. doi: 10.1002/hbm.25981.
Afzali-Hashemi L, Václavů L, Wood JC, Biemond BJ, Nederveen AJ, Mutsaerts HJMM, Schrantee A. Assessment of functional shunting in patients with sickle cell disease. Haematologica. 2022 May 12. doi: 10.3324/haematol.2021.280183.
van Ruiten CC, Veltman DJ, Schrantee A, van Bloemendaal L, Barkhof F, Kramer MHH, Nieuwdorp M, IJzerman RG. Effects of dapagliflozin and combination therapy with exenatide on food-cue induced brain activation in patients with type 2 diabetes. J Clin Endocrinol Metab. 2022 :dgac043. doi: 10.1210/clinem/dgac043.
Kaiser A, Reneman L, Solleveld MM, Coolen BF, Scherder EJA, Knutsson L, Bjørnerud A, van Osch MJP, Wijnen JP, Lucassen PJ, Schrantee A. A Randomized Controlled Trial on the Effects of a 12-Week High- vs. Low-Intensity Exercise Intervention on Hippocampal Structure and Function in Healthy, Young Adults. Front Psychiatry. 2022 Jan 21;12:780095. doi: 10.3389/fpsyt.2021.780095.

2021

Schalbroeck R, de Geus-Oei LF, Selten JP, Yaqub M, Schrantee A, van Amelsvoort T, Booij J, van Velden FHP. Cerebral [¹⁸F]-FDOPA Uptake in Autism Spectrum Disorder and Its Association with Autistic Traits. Diagnostics (Basel). 2021 Dec 20;11(12):2404. doi: 10.3390/diagnostics11122404.
Koert A, Ploeger A, Bockting CLH, Schmidt MV, Lucassen PJ, Schrantee A, Mul JD. The social instability stress paradigm in rat and mouse: A systematic review of protocols, limitations, and recommendations. Neurobiol Stress. 2021 Oct 16;15:100410. doi: 10.1016/j.ynstr.2021.100410.
Kaiser A, Reneman L, Lucassen PJ, de Vries TJ, Schrantee A, Kaag AM. Targeting working memory to modify emotional reactivity in adult attention deficit hyperactivity disorder: a functional magnetic resonance imaging study. Brain Imaging Behav. 2021 Sep 15. doi: 10.1007/s11682-021-00532-6.
van de Stadt SIW, Schrantee A, Huffnagel IC, van Ballegoij WJC, Caan MWA, Pouwels PJW, Engelen M. Magnetic resonance spectroscopy as marker for neurodegeneration in X-linked adrenoleukodystrophy. Neuroimage Clin. 2021;32:102793. doi: 10.1016/j.nicl.2021.102793.
van Galen KA, Booij J, Schrantee A, Adriaanse SM, Unmehopa UA, Fliers E, Schwartz GJ, DiLeone RJ, Ter Horst KW, la Fleur SE, Serlie MJ. The response to prolonged fasting in hypothalamic serotonin transporter availability is blunted in obesity. Metabolism. 2021 Oct;123:154839. doi: 10.1016/j.metabol.2021.154839
Hui SCN, Mikkelsen M, Zöllner HJ, Ahluwalia V, Alcauter S, Baltusis L, Barany DA, Barlow LR, Becker R, Berman JI, Berrington A, Bhattacharyya PK, Blicher JU, Bogner W, Brown MS, Calhoun VD, Castillo R, Cecil KM, Choi YB, Chu WCW, Clarke WT, Craven AR, Cuypers K, Dacko M, de la Fuente-Sandoval C, Desmond P, Domagalik A, Dumont J, Duncan NW, Dydak U, Dyke K, Edmondson DA, Ende G, Ersland L, Evans CJ, Fermin ASR, Ferretti A, Fillmer A, Gong T, Greenhouse I, Grist JT, Gu M, Harris AD, Hat K, Heba S, Heckova E, Hegarty JP 2nd, Heise KF, Honda S, Jacobson A, Jansen JFA, Jenkins CW, Johnston SJ, Juchem C, Kangarlu A, Kerr AB, Landheer K, Lange T, Lee P, Levendovszky SR, Limperopoulos C, Liu F, Lloyd W, Lythgoe DJ, Machizawa MG, MacMillan EL, Maddock RJ, Manzhurtsev AV, Martinez-Gudino ML, Miller JJ, Mirzakhanian H, Moreno-Ortega M, Mullins PG, Nakajima S, Near J, Noeske R, Nordhøy W, Oeltzschner G, Osorio-Duran R, Otaduy MCG, Pasaye EH, Peeters R, Peltier SJ, Pilatus U, Polomac N, Porges EC, Pradhan S, Prisciandaro JJ, Puts NA, Rae CD, Reyes-Madrigal F, Roberts TPL, Robertson CE, Rosenberg JT, Rotaru DG, O’Gorman Tuura RL, Saleh MG, Sandberg K, Sangill R, Schembri K, Schrantee A, Semenova NA, Singel D, Sitnikov R, Smith J, Song Y, Stark C, Stoffers D, Swinnen SP, Tain R, Tanase C, Tapper S, Tegenthoff M, Thiel T, Thioux M, Truong P, van Dijk P, Vella N, Vidyasagar R, Vovk A, Wang G, Westlye LT, Wilbur TK, Willoughby WR, Wilson M, Wittsack HJ, Woods AJ, Wu YC, Xu J, Lopez MY, Yeung DKW, Zhao Q, Zhou X, Zupan G, Edden RAE. Frequency drift in MR spectroscopy at 3T. Neuroimage. 2021 Nov 1;241:118430. doi: 10.1016/j.neuroimage.2021.118430.
Campos AI, Thompson PM, Veltman DJ, Pozzi E, van Veltzen LS, Jahanshad N, Adams MJ, Baune BT, Berger K, Brosch K, Bülow R, Connolly CG, Dannlowski U, Davey CG, de Zubicaray GI, Dima D, Erwin-Grabner T, Evans JW, Fu CHY, Gotlib IH, Goya-Maldonado R, Grabe HJ, Grotegerd D, Harris MA, Harrison BJ, Hatton SN, Hermesdorf M, Hickie IB, Ho TC, Kircher T, Krug A, Lagopoulos J, Lemke H, McMahon K, MacMaster FP, Martin NG, McIntosh AM, Medland SE, Meinert S, Meller T, Nenadic I, Opel N, Redlich R, Reneman L, Repple J, Sacchet MD, Schmitt S, Schrantee A, Sim K, Singh A, Stein F, Strike LT, van der Wee NJA, van der Werff SJA, Völzke H, Waltemate L, Whalley HC, Wittfeld K, Wright MJ, Yang TT, Zarate CA, Schmaal L, Rentería ME; ENIGMA-MDD Working Group. Brain Correlates of Suicide Attempt in 18,925 Participants Across 18 International Cohorts. Biol Psychiatry. 2021 Aug 15;90(4):243-252. doi: 10.1016/j.biopsych.2021.03.015.
Buijink AWG, Prent N, Puts NA, Schrantee A, Potters WV, van Rootselaar AF. GABA, Glutamate, and NAA Levels in the Deep Cerebellar Nuclei of Essential Tremor Patients. Front Neurol. 2021 May 6;12:664735. doi: 10.3389/fneur.2021.664735.
Reneman L, van der Pluijm M, Schrantee A, van de Giessen E. Imaging of the dopamine system with focus on pharmacological MRI and neuromelanin imaging. Eur J Radiol. 2021 Jul;140:109752. doi: 10.1016/j.ejrad.2021.109752.
Hilberdink CE, van Zuiden M, Schrantee A, Korosi A, Kaiser A, Zhutovsky P, Ginty AT, Ensink JBM, Lindauer RJL, Vrijkotte TGM, de Rooij SR. Dysregulated functional brain connectivity in response to acute social-evaluative stress in adolescents with PTSD symptoms. Eur J Psychotraumatol. 2021 Mar 25;12(1):1880727. doi: 10.1080/20008198.2021.1880727.
Afzali-Hashemi L, Baas KPA, Schrantee A, Coolen BF, van Osch MJP, Spann SM, Nur E, Wood JC, Biemond BJ, Nederveen AJ. Impairment of Cerebrovascular Hemodynamics in Patients With Severe and Milder Forms of Sickle Cell Disease. Front Physiol. 2021 Apr 20;12:645205. doi: 10.3389/fphys.2021.645205.
Tahmasian M, Aleman A, Andreassen OA, Arab Z, Baillet M, Benedetti F, Bresser T, Bright J, Chee MWL, Chylinski D, Cheng W, Deantoni M, Dresler M, Eickhoff SB, Eickhoff CR, Elvsåshagen T, Feng J, Foster-Dingley JC, Ganjgahi H, Grabe HJ, Groenewold NA, Ho TC, Bong Hong S, Houenou J, Irungu B, Jahanshad N, Khazaie H, Kim H, Koshmanova E, Kocevska D, Kochunov P, Lakbila-Kamal O, Leerssen J, Li M, Luik AI, Muto V, Narbutas J, Nilsonne G, O’Callaghan VS, Olsen A, Osorio RS, Poletti S, Poudel G, Reesen JE, Reneman L, Reyt M, Riemann D, Rosenzweig I, Rostampour M, Saberi A, Schiel J, Schmidt C, Schrantee A, Sciberras E, Silk TJ, Sim K, Smevik H, Soares JC, Spiegelhalder K, Stein DJ, Talwar P, Tamm S, Teresi GL, Valk SL, Van Someren E, Vandewalle G, Van Egroo M, Völzke H, Walter M, Wassing R, Weber FD, Weihs A, Westlye LT, Wright MJ, Wu MJ, Zak N, Zarei M. ENIGMA-Sleep: Challenges, opportunities, and the road map. J Sleep Res. 2021 Dec;30(6):e13347. doi: 10.1111/jsr.13347.
Li T, van Rooij D, Roth Mota N, Buitelaar JK, Schrantee A (ENIGMA-ADHD working group), Hoogman M, Arias Vasquez A, Franke B. Characterizing neuroanatomic heterogeneity in people with and without ADHD based on subcortical brain volumes. J Child Psychol Psychiatry. 2021 Sep;62(9):1140-1149. doi: 10.1111/jcpp.13384.
Postema MC, Hoogman M, …, Schrantee A (ENIGMA working groups), …, Glahn DC, Jahanshad N, Medland SE; ENIGMA ADHD Working Group, Thompson PM, Fisher SE, Franke B, Francks C. Analysis of structural brain asymmetries in attention-deficit/hyperactivity disorder in 39 datasets. J Child Psychol Psychiatry. 2021 Oct;62(10):1202-1219. doi: 10.1111/jcpp.13396.
Tamminga HGH, Reneman L, Schrantee A, Bottelier MA, Bouziane C, Geurts HM, Groenman AP. Do effects of methylphenidate on cognitive performance last beyond treatment? A randomized placebo-controlled trial in boys and men with ADHD. Eur Neuropsychopharmacol. 2021 May;46:1-13. doi: 10.1016/j.euroneuro.2021.02.002.
Van den Hof M, Jellema PEJ, Ter Haar AM, Scherpbier HJ, Schrantee A, Kaiser A, Caan MWA, Majoie CBLM, Reiss P, Wit FWNM, Mutsaerts HMM, Pajkrt D. Normal structural brain development in adolescents treated for perinatally acquired HIV: a longitudinal imaging study. AIDS. 2021 Jul 1;35(8):1221-1228. doi: 10.1097/QAD.0000000000002873.
Zhang-James Y, Helminen EC, Liu J; Schrantee A (ENIGMA-ADHD working group), Franke B, Hoogman M, Faraone SV. Evidence for similar structural brain anomalies in youth and adult attention-deficit/hyperactivity disorder: a machine learning analysis. Transl Psychiatry. 2021 Feb 1;11(1):82. doi: 10.1038/s41398-021-01201-4.

2020

Welsink-Karssies MM, Schrantee A, Caan MWA, Hollak CEM, Janssen MCH, Oussoren E, de Vries MC, Roosendaal SD, Engelen M, Bosch AM. Gray and white matter are both affected in classical galactosemia: An explorative study on the association between neuroimaging and clinical outcome. Mol Genet Metab. 2020 Dec;131(4):370-379. doi: 10.1016/j.ymgme.2020.11.001.
Wezenberg BN, Hagen JM, Sutterland AL, Schrantee A, de Haan L. Association between Advanced Glycation End products and brain volumes in recent onset psychosis. Schizophr Res. 2020 Oct;224:181-182. doi: 10.1016/j.schres.2020.09.010.
Arnts H, van Erp WS, Boon LI, Bosman CA, Admiraal MM, Schrantee A, Pennartz CMA, Schuurman R, Stam CJ, van Rootselaar AF, Hillebrand A, van den Munckhof P. Awakening after a sleeping pill: Restoring functional brain networks after severe brain injury. Cortex. 2020 Nov;132:135-146. doi: 10.1016/j.cortex.2020.08.011.
Hartstra AV, Schüppel V, Imangaliyev S, Schrantee A, Prodan A, Collard D, Levin E, Dallinga-Thie G, Ackermans MT, Winkelmeijer M, Havik SR, Metwaly A, Lagkouvardos I, Nier A, Bergheim I, Heikenwalder M, Dunkel A, Nederveen AJ, Liebisch G, Mancano G, Claus SP, Benítez-Páez A, la Fleur SE, Bergman JJ, Gerdes V, Sanz Y, Booij J, Kemper E, Groen AK, Serlie MJ, Haller D, Nieuwdorp M. Infusion of donor feces affects the gut-brain axis in humans with metabolic syndrome. Mol Metab. 2020 Dec;42:101076. doi: 10.1016/j.molmet.2020.101076.
Patel Y, Parker N, Shin J, Howard D, French L, Thomopoulos SI, Pozzi E, …, Schrantee A (ENIGMA working groups), …, Franke B, Hoogman M, Buitelaar JK, van Rooij D, Andreassen OA, Ching CRK, Veltman DJ, Schmaal L, Stein DJ, van den Heuvel OA, Turner JA, van Erp TGM, Pausova Z, Thompson PM, Paus T. Virtual Histology of Cortical Thickness and Shared Neurobiology in 6 Psychiatric Disorders. JAMA Psychiatry. 2021 Jan 1;78(1):47-63. doi: 10.1001/jamapsychiatry.2020.2694.
Solleveld MM, Schrantee A, Homberg JR, Lucassen PJ, Reneman L. The influence of age-of-onset of antidepressant use on the acute CBF response to a citalopram challenge; a pharmacological MRI study. Psychiatry Res Neuroimaging. 2020 Sep 30;303:111126. doi: 10.1016/j.pscychresns.2020.111126.
Boedhoe PSW, van Rooij D, Hoogman M, Twisk JWR, Schmaal L, …, Schrantee A (ENIGMA working group), …, Thompson PM, Stein DJ, Buitelaar J, Franke B, van den Heuvel OA. Subcortical Brain Volume, Regional Cortical Thickness, and Cortical Surface Area Across Disorders: Findings From the ENIGMA ADHD, ASD, and OCD Working Groups. Am J Psychiatry. 2020 Sep 1;177(9):834-843. doi: 10.1176/appi.ajp.2020.19030331.
Mutsaerts HJMM, Petr J, Groot P, Vandemaele P, Ingala S, Robertson AD, Václavů L, Groote I, Kuijf H, Zelaya F, O’Daly O, Hilal S, Wink AM, Kant I, Caan MWA, Morgan C, de Bresser J, Lysvik E, Schrantee A, Bjørnebekk A, Clement P, Shirzadi Z, Kuijer JPA, Wottschel V, Anazodo UC, Pajkrt D, Richard E, Bokkers RPH, Reneman L, Masellis M, Günther M, MacIntosh BJ, Achten E, Chappell MA, van Osch MJP, Golay X, Thomas DL, De Vita E, Bjørnerud A, Nederveen A, Hendrikse J, Asllani I, Barkhof F. ExploreASL: An image processing pipeline for multi-center ASL perfusion MRI studies. Neuroimage. 2020 Oct 1;219:117031. doi: 10.1016/j.neuroimage.2020.117031.
Schmaal L, Pozzi E, C Ho T, van Velzen LS, Veer IM, Opel N, Van Someren EJW, Han LKM, Aftanas L, Aleman A, Baune BT, Berger K, Blanken TF, Capitão L, Couvy-Duchesne B, R Cullen K, Dannlowski U, Davey C, Erwin-Grabner T, Evans J, Frodl T, Fu CHY, Godlewska B, Gotlib IH, Goya-Maldonado R, Grabe HJ, Groenewold NA, Grotegerd D, Gruber O, Gutman BA, Hall GB, Harrison BJ, Hatton SN, Hermesdorf M, Hickie IB, Hilland E, Irungu B, Jonassen R, Kelly S, Kircher T, Klimes-Dougan B, Krug A, Landrø NI, Lagopoulos J, Leerssen J, Li M, Linden DEJ, MacMaster FP, M McIntosh A, Mehler DMA, Nenadić I, Penninx BWJH, Portella MJ, Reneman L, Rentería ME, Sacchet MD, G Sämann P, Schrantee A, Sim K, Soares JC, Stein DJ, Tozzi L, van Der Wee NJA, van Tol MJ, Vermeiren R, Vives-Gilabert Y, Walter H, Walter M, Whalley HC, Wittfeld K, Whittle S, Wright MJ, Yang TT, Zarate C Jr, Thomopoulos SI, Jahanshad N, Thompson PM, Veltman DJ. ENIGMA MDD: seven years of global neuroimaging studies of major depression through worldwide data sharing. Transl Psychiatry. 2020 May 29;10(1):172. doi: 10.1038/s41398-020-0842-6.
Opel N, Thalamuthu A, Milaneschi Y, Grotegerd D, Flint C, Leenings R, Goltermann J, Richter M, Hahn T, Woditsch G, Berger K, Hermesdorf M, McIntosh A, Whalley HC, Harris MA, MacMaster FP, Walter H, Veer IM, Frodl T, Carballedo A, Krug A, Nenadic I, Kircher T, Aleman A, Groenewold NA, Stein DJ, Soares JC, Zunta-Soares GB, Mwangi B, Wu MJ, Walter M, Li M, Harrison BJ, Davey CG, Cullen KR, Klimes-Dougan B, Mueller BA, Sämann PG, Penninx B, Nawijn L, Veltman DJ, Aftanas L, Brak IV, Filimonova EA, Osipov EA, Reneman L, Schrantee A, Grabe HJ, Van der Auwera S, Wittfeld K, Hosten N, Völzke H, Sim K, Gotlib IH, Sacchet MD, Lagopoulos J, Hatton SN, Hickie I, Pozzi E, Thompson PM, Jahanshad N, Schmaal L, Baune BT, Dannlowski U. Brain structural abnormalities in obesity: relation to age, genetic risk, and common psychiatric disorders : Evidence through univariate and multivariate mega-analysis including 6420 participants from the ENIGMA MDD working group. Mol Psychiatry. 2021 Sep;26(9):4839-4852. doi: 10.1038/s41380-020-0774-9.
Han LKM, Dinga R, Hahn T, Ching CRK, Eyler LT, …, Schrantee A (ENIGMA working group), …, Jahanshad N, Thompson PM, Veltman DJ, Penninx BWJH, Marquand AF, Cole JH, Schmaal L. Brain aging in major depressive disorder: results from the ENIGMA major depressive disorder working group. Mol Psychiatry. 2021 Sep;26(9):5124-5139. doi: 10.1038/s41380-020-0754-0.
Walhovd KB, Amlien I, Schrantee A, Rohani DA, Groote I, Bjørnerud A, Fjell AM, Reneman L. Methylphenidate Effects on Cortical Thickness in Children and Adults with Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial. AJNR Am J Neuroradiol. 2020 May;41(5):758-765. doi: 10.3174/ajnr.A6560.
van Sandwijk MS, Ten Berge IJM, Caan MWA, Düring M, van Gool WA, Majoie CBLM, Mutsaerts HMM, Schmand BA, Schrantee A, de Sonneville LMJ, Bemelman FJ. Cognitive Improvement After Kidney Transplantation Is Associated With Structural and Functional Changes on MRI. Transplant Direct. 2020 Feb 10;6(3):e531. doi: 10.1097/TXD.0000000000000976.
Solleveld MM, Schrantee A, Baek HK, Bottelier MA, Tamminga HGH, Bouziane C, Stoffelsen R, Lucassen PJ, Van Someren EJW, Rijsman RM, Reneman L. Effects of 16 Weeks of Methylphenidate Treatment on Actigraph-Assessed Sleep Measures in Medication-Naive Children With ADHD. Front Psychiatry. 2020 Feb 28;11:82. doi: 10.3389/fpsyt.2020.00082.
Schrantee A, Ruhé HG, Reneman L. Psychoradiological Biomarkers for Psychopharmaceutical Effects. Neuroimaging Clin N Am. 2020 Feb;30(1):53-63. doi: 10.1016/j.nic.2019.09.006.

2019

Bouziane C, Filatova OG, Schrantee A, Caan MWA, Vos FM, Reneman L. White Matter by Diffusion MRI Following Methylphenidate Treatment: A Randomized Control Trial in Males with Attention-Deficit/Hyperactivity Disorder. Radiology. 2019 Oct;293(1):186-192. doi: 10.1148/radiol.2019182528.
de Kovel CGF, …, Schrantee A (ENIGMA working group), … Thompson PM, Veltman DJ, Schmaal L, Francks C. No Alterations of Brain Structural Asymmetry in Major Depressive Disorder: An ENIGMA Consortium Analysis. Am J Psychiatry. 2019 Dec 1;176(12):1039-1049. doi: 10.1176/appi.ajp.2019.18101144.
Vingerhoets C, Bakker G, Schrantee A, van der Pluijm M, Bloemen OJN, Reneman L, Caan M, Booij J, van Amelsvoort TAMJ. Influence of muscarinic M₁ receptor antagonism on brain choline levels and functional connectivity in medication-free subjects with psychosis: A placebo controlled, cross-over study. Psychiatry Res Neuroimaging. 2019 Aug 30;290:5-13. doi: 10.1016/j.pscychresns.2019.06.005.
Hoogman M, Muetzel R, …, Schrantee A (ENIGMA working group), …, Thompson PM, Buitelaar JK, Faraone SV, Shaw P, Tiemeier H, Bralten J, Franke B. Brain Imaging of the Cortex in ADHD: A Coordinated Analysis of Large-Scale Clinical and Population-Based Samples. Am J Psychiatry. 2019 Jul 1;176(7):531-542. doi: 10.1176/appi.ajp.2019.18091033.
Schrantee A, Solleveld MM, Schwantje H, Bruin WB, Mutsaerts HM, Adriaanse SM, Lucassen P, Booij J, Reneman L. Dose-dependent effects of the selective serotonin reuptake inhibitor citalopram: A combined SPECT and phMRI study. J Psychopharmacol. 2019 Jun;33(6):660-669. doi: 10.1177/0269881119836229.

2018

Schrantee A, Lucassen PJ, Booij J, Reneman L. Serotonin transporter occupancy by the SSRI citalopram predicts default-mode network connectivity. Eur Neuropsychopharmacol. 2018 Oct;28(10):1173-1179. doi: 10.1016/j.euroneuro.2018.07.099.
Schrantee A, Bouziane C, Bron EE, Klein S, Bottelier MA, Kooij JJS, Rombouts SARB, Reneman L. Long-term effects of stimulant exposure on cerebral blood flow response to methylphenidate and behavior in attention-deficit hyperactivity disorder. Brain Imaging Behav. 2018 Apr;12(2):402-410. doi: 10.1007/s11682-017-9707-x.

2017

Bouziane C, Caan MWA, Tamminga HGH, Schrantee A, Bottelier MA, de Ruiter MB, Kooij SJJ, Reneman L. ADHD and maturation of brain white matter: A DTI study in medication naive children and adults. Neuroimage Clin. 2017 Sep 29;17:53-59. doi: 10.1016/j.nicl.2017.09.026.
Bottelier MA, Schrantee A, Ferguson B, Tamminga HGH, Bouziane C, Kooij JJS, de Ruiter MB, Reneman L. Age-dependent effects of acute methylphenidate on amygdala reactivity in stimulant treatment-naive patients with Attention Deficit/Hyperactivity Disorder. Psychiatry Res Neuroimaging. 2017 Nov 30;269:36-42. doi: 10.1016/j.pscychresns.2017.09.009.
Solleveld MM, Schrantee A, Puts NAJ, Reneman L, Lucassen PJ. Age-dependent, lasting effects of methylphenidate on the GABAergic system of ADHD patients. Neuroimage Clin. 2017 Jun 2;15:812-818. doi: 10.1016/j.nicl.2017.06.003.
Versteeg RI, Schrantee A, Adriaanse SM, Unmehopa UA, Booij J, Reneman L, Fliers E, la Fleur SE, Serlie MJ. Timing of caloric intake during weight loss differentially affects striatal dopamine transporter and thalamic serotonin transporter binding. FASEB J. 2017 Oct;31(10):4545-4554. doi: 10.1096/fj.201601234R.
Schrantee A, Václavů L, Reneman L, Verberne HJ, Booij J, Tan HL. QT prolongation by dexamphetamine: Does experience matter? J Cardiovasc Electrophysiol. 2017 Aug;28(8):912-916. doi: 10.1111/jce.13235. Epub 2017 Jun 21. PMID: 28452189.
Schrantee A, Tremoleda JL, Wylezinska-Arridge M, Bouet V, Hesseling P, Meerhoff GF, de Bruin KM, Koeleman J, Freret T, Boulouard M, Desfosses E, Galineau L, Gozzi A, Dauphin F, Gsell W, Booij J, Lucassen PJ, Reneman L. Repeated dexamphetamine treatment alters the dopaminergic system and increases the phMRI response to methylphenidate. PLoS One. 2017 Feb 27;12(2):e0172776. doi: 10.1371/journal.pone.0172776.

2016

Schrantee A, Mutsaerts H, Bouziane C, Tamminga H, Bottelier MA, Reneman L. The age-dependent effects of a single-dose methylphenidate challenge on cerebral perfusion in patients with attention-deficit/hyperactivity disorder. Neuroimage Clin. 2016 Nov 21;13:123-129. doi: 10.1016/j.nicl.2016.11.021.
Schrantee A, Tamminga HG, Bouziane C, Bottelier MA, Bron EE, Mutsaerts HJ, Zwinderman AH, Groote IR, Rombouts SA, Lindauer RJ, Klein S, Niessen WJ, Opmeer BC, Boer F, Lucassen PJ, Andersen SL, Geurts HM, Reneman L. Age-Dependent Effects of Methylphenidate on the Human Dopaminergic System in Young vs Adult Patients With Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2016 Sep 1;73(9):955-62. doi: 10.1001/jamapsychiatry.2016.1572.
Schrantee A, Ferguson B, Stoffers D, Booij J, Rombouts S, Reneman L. Effects of dexamphetamine-induced dopamine release on resting-state network connectivity in recreational amphetamine users and healthy controls. Brain Imaging Behav. 2016 Jun;10(2):548-58. doi: 10.1007/s11682-015-9419-z.

2015

Schrantee A, Václavů L, Heijtel DF, Caan MW, Gsell W, Lucassen PJ, Nederveen AJ, Booij J, Reneman L. Dopaminergic system dysfunction in recreational dexamphetamine users. Neuropsychopharmacology. 2015 Mar 13;40(5):1172-80. doi:10.1038/npp.2014.301

2014

Bottelier MA, Schouw ML, Klomp A, Tamminga HG, Schrantee A, Bouziane C, de Ruiter MB, Boer F, Ruhé HG, Denys D, Rijsman R, Lindauer RJ, Reitsma HB, Geurts HM, Reneman L. The effects of Psychotropic drugs On Developing brain (ePOD) study: methods and design. BMC Psychiatry. 2014 Feb 19;14:48. doi: 10.1186/1471-244X-14-48.
Schrantee A, Reneman L. Pharmacological imaging as a tool to visualise dopaminergic neurotoxicity. Neuropharmacology. 2014;84:159-169. doi:10.1016/j.neuropharm.2013.06.029

2013

Perkins AM, Ettinger U, Weaver K, Schmechtig A, Schrantee A, Morrison PD, Sapara A, Kumari V, Williams SC, Corr PJ. Advancing the defensive explanation for anxiety disorders: lorazepam effects on human defense are systematically modulated by personality and threat-type. Transl Psychiatry. 2013 Apr 16;3(4):e246. doi:10.1038/tp.2013.20

2012

Klomp A, Tremoleda JL, Schrantee A, Gsell W, Reneman L. The use of pharmacological-challenge fMRI in pre-clinical research: application to the 5-HT system. J Vis Exp. 2012;(62):3956. doi:10.3791/3956